Author:
Bansal Meenakshi,Kumari Pooja,Malik Rajender Singh,Grishina Maria,Singh Devender,Rathi Brijesh,Kumar Sumit
Publisher
Springer Nature Singapore
Reference133 articles.
1. Abdelhafez OM, Amin KM, Batran RZ, Maher TJ, Nada SA, Sethumadhavan S (2010) Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives. Bioorg Med Chem 18(10):3371–3378
2. Abras A, Ballart C, Fernández-Arévalo A, Pinazo M-J, Gascón J, Muñoz C, Gállego M (2022) Worldwide control and management of chagas disease in a new era of globalization: a close look at congenital trypanosoma cruzi infection. Clin Microbiol Rev 35(2):e00152–e00121
3. Al-Amiery AA, Kadhum AAH, Mohamad AB (2012) Antifungal activities of new coumarins. Molecules 17(5):5713–5723
4. Ali MI, Rauf MK, Badshah A, Kumar I, Forsyth CM, Junk PC, Kedzierski L, Andrews PC (2013) Anti-leishmanial activity of heteroleptic organometallic Sb (V) compounds. Dalton Trans 42(48):16733–16741
5. Álvarez-Hernández D-A, García-Rodríguez-Arana R, Ortiz-Hernández A, Álvarez-Sánchez M, Wu M, Mejia R, Martínez-Juárez L-A, Montoya A, Gallardo-Rincon H, Vázquez-López R (2021) A systematic review of historical and current trends in chagas disease. Ther Adv Infect Dis 8:20499361211033715